Next, to evaluate whether the therapeutic effect of ONO-1301 varied depending on the status of NASH, we divided the mice into three groups as follows: In the Ctl group, the Mc4r-KO mouse fed ND until 8 weeks, following which WD was fed until 28 weeks after birth. The gene discussed is MC4R; the disease is metabolic dysfunction-associated steatohepatitis.